The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients

March 2, 2026 updated by: Doç.Dr.Ömer Şevgin, Uskudar University

The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients: A Randomized Controlled Study

This study aims to contribute to clinical applications by investigating the effectiveness of functional rotation exercises on fall risk, mobility, and balance in patients diagnosed with idiopathic Parkinson's disease.

Study Overview

Detailed Description

This study aims to investigate the clinical effects of functional rotation exercises on fall risk and mobility in individuals with Parkinson's disease. Participants will be randomly divided into two groups: a control group and an experimental group. Demographic characteristics of all participants will be collected, and then the Timed Up and Walk Test will be used to assess fall risk, the 10-Meter Walk Test to assess mobility, and the Berg Balance Scale to assess functional balance. An extra exercise program will be applied to participants in the experimental group.

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Sancaktepe
      • Istanbul, Sancaktepe, Turkey (Türkiye)
        • Recruiting
        • Sancak Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria

  • Individuals with a clinical diagnosis of idiopathic Parkinson's disease (Hoehn & Yahr stages 1-2)
  • Individuals aged 50-70 years
  • Mini Mental State Test score ≥ 24
  • Individuals whose medical treatment has been stable in the last 6 weeks
  • Individuals with stable vital signs
  • Individuals who volunteer to participate in the study and understand the purpose and process of the study, and who have signed a written informed consent form

Exclusion Criteria

  • Advanced Parkinson's disease (H&Y 3-5)
  • Severe orthopedic problems
  • Vestibular system disorders
  • History of serious falls in the last 6 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: control group
only patients who will receive a conventional physiotherapy program

Conventional physiotherapy will be applied for 6 weeks, with 3 sessions per week, each session lasting approximately 40-50 minutes.

Participants will be given stretching and flexibility exercises (trunk, shoulder and lower extremity muscle groups) in each session, with 10 repetitions x 15 seconds. Balance exercises (3 repetitions for 30-45 seconds in static and dynamic balance positions), walking exercises on a flat surface, and strengthening exercises (2-3 sets, 10-12 repetitions with resistance band or dumbbells) will be performed.

Experimental: exercise group
Patients who will receive a special exercise program in addition to a conventional physiotherapy program.

Conventional physiotherapy will be applied for 6 weeks, with 3 sessions per week, each session lasting approximately 40-50 minutes.

Participants will be given stretching and flexibility exercises (trunk, shoulder and lower extremity muscle groups) in each session, with 10 repetitions x 15 seconds. Balance exercises (3 repetitions for 30-45 seconds in static and dynamic balance positions), walking exercises on a flat surface, and strengthening exercises (2-3 sets, 10-12 repetitions with resistance band or dumbbells) will be performed.

This group will receive conventional physical therapy and functional rotation exercises for 6 weeks, with 3 sessions per week, each session lasting approximately 40-50 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Timed Up and Go Test
Time Frame: 10 weeks
This outcome measure will be used to assess functional mobility using a virtual reality-based adaptation of the Timed Up and Go test. Test completion time will be automatically recorded by the system. Validity and reliability will be examined through comparison with the conventional Timed Up and Go test and repeated measurements.
10 weeks
Berg Balance Test
Time Frame: 10 weeks
Berg Balance Test is consisting of 14 items and measures the ability of individuals to maintain balance while performing functional tasks. Each task is scored from 0 (cannot perform independently) to 4 (stated best performance). 0-20 points are interpreted as high risk of falling, between 21-40 points as medium risk of falling, and between 41-56 points as low risk.
10 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Kübra UZUN, Uskudar University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2026

Primary Completion (Estimated)

July 15, 2026

Study Completion (Estimated)

September 15, 2026

Study Registration Dates

First Submitted

February 25, 2026

First Submitted That Met QC Criteria

February 25, 2026

First Posted (Actual)

March 2, 2026

Study Record Updates

Last Update Posted (Actual)

March 3, 2026

Last Update Submitted That Met QC Criteria

March 2, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson Disease

Clinical Trials on conventional physiotherapy

Subscribe